San Diego, CA, United States of America

Laurence Altobell, Iii

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Anaptysbio, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence Altobell, Iii. Retrieved from https://idiyas.com/inventor/laurence-altobell-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Laurence Altobell, III

Introduction

Laurence Altobell, III is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His work focuses on innovative solutions for treating diseases mediated by interleukin-17 (IL-17).

Latest Patents

Altobell holds a patent for "Antibodies directed against IL-17." This invention relates to an isolated IL-17-binding agent that includes specific immunoglobulin heavy and light chain polypeptides. The patent outlines the potential for these agents to be used in vectors, compositions, and methods aimed at treating IL-17-mediated diseases.

Career Highlights

Laurence Altobell, III is associated with Anaptysbio, Inc., where he continues to advance his research and development efforts. His work has been instrumental in the exploration of new therapeutic avenues in immunology.

Collaborations

He has collaborated with notable colleagues such as Robert A. Horlick and David J. King, contributing to a dynamic research environment that fosters innovation.

Conclusion

Laurence Altobell, III exemplifies the spirit of innovation in biotechnology through his patent and ongoing work at Anaptysbio, Inc. His contributions are paving the way for new treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…